Down-regulation of Na+ transporters and AQP2 is responsible for acyclovir-induced polyuria and hypophosphatemia

Kidney International

Volumn 65, Issue 1, 2004, Pages 175-183

  Andrade, Lúcia ^a   Rebouças, Nancy A ^b   Seguro, Antonio Carlos ^b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b NONE

Author keywords

Acyclovir; Hypophosphatemia; Polyuria

Indexed keywords

ACICLOVIR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CRYSTALLURIA; DRUG INDUCED DISEASE; HYPOPHOSPHATEMIA; INULIN CLEARANCE; KIDNEY CONCENTRATING CAPACITY; MALE; METABOLIC ACTIVATION; NONHUMAN; NORTHERN BLOTTING; POLYURIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RECEPTOR DOWN REGULATION; SODIUM EXCRETION; SODIUM TRANSPORT; URINE OSMOLALITY; VARICELLA ZOSTER VIRUS;

EID: 0347362499     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1523-1755.2004.00359.x     Document Type: Article

References (38)

1. SNOECK R, ANDREI G, DE CLERCQ E: Current pharmacological approaches to the therapy of varicella zoster virus infection. Drugs 57(2):187-206, 1999
2. HAYDEN FG: Antiviral agents, in The Pharmacological Basis of Therapeutics, edited by Hardman JG, Gilman AG, New York, McGraw-Hill, 1996, pp 1191-1223
3. BLUM MR, LIAO SH, MIRANDA P: Overview of Acyclovir pharmacokinetic disposition in adults and children. Am J Med 73(1 A):186-192, 1982
4. BIANCHETTI MG, RODUIT C, OETLIKER OH: Acyclovir-induced renal failure: Course and risk factors. Pediatr Nephrol 5:238-239, 1991
5. PERAZELLA MA: Crystal-induced acute renal failure. Am J Med 106(4):459-465, 1999
6. CAMPOS SB, SEGURO AC, CESAR KR, ROCHA AS: Effects of Acyclovir on renal function. Nephron 62:74-79, 1992
7. MONTEIRO JL, CASTRO I, SEGURO AC: Hypophosphatemia induced by Acyclovir. Transplantation 55(3):680-682, 1993
8. CHOMCZYNSKI P, SACCHI N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159, 1987
9. CHURCH GM, GILBERT W: Genomic sequencing. Proc Natl Acad Sci USA 81:1991-1995, 1984
10. MURER H, HERNANDO N, FORSTER I, BIBER J: Proximal tubular phosphate reabsorption: Molecular mechanisms. Physiol Rev 80:1373-1409, 2000
11. ELION GB: Mechanism of action selectivity of acyclovir. Am J Med 73(1A):7-13, 1982
12. ELION GB: Acyclovir: Discovery, mechanism of action, and selectivity. J Med Virol 1 (Suppl):2-6, 1993
13. LASKIN OL, MIRANDA P, KING DH, et al: Effects of probenecid on the pharmacokinetics and elimination of Acyclovir in humans. Antimicrob Agents Chemother 21(5);804-805, 1982
14. SCHAEFFER H. Acyclovir chemistry and spectrum of action. Am J Med 73(1 A):4-6, 1982
15. KAPLAN MR, PLOTKIN MD, LEE W-S, et al: Apical localization of the Na-K-Cl cotransporter, rBSC1, on membranes of thick ascending limbs. Kidney Int 49:40-47, 1996
16. - cotransporter, BSC-1. Am J Physiol 271:F619-F628, 1996
17. WANG W, KWON TH, LI C, et al: Reduced expression of Na-k-2Cl cotransporter in medullary TAL in vitamin D-induced hypercalcemia in rats. Am J Physiol 282:F34-F44, 2002
18. SUKI W, ROUSE D: Renal transport of calcium, magnesium and phosphate, in The Kidney (vol 1), edited by Brenner BM, Philadelphia, W.B. Saunders Company, 1996, pp 472-515
19. QUAMME GA, DIRKS JH: Magnesium metabolism, in Clinical Disorders of Fluid and Electrolyte Metabolism (5th ed), edited by Narins R, New York, 1994, pp 373-399
20. RUSSEL JM: Sodium-potassium-chloride cotransport. Physiol Rev 80:211-276, 2000
21. BERNS JS, COHEN RM, STUMACHER RJ, RUDNICK MR: Renal aspects of therapy for human immunodeficiency virus and associated opportunistic infections. J Am Soc Nephrol 1:1061-1080, 1991
22. SAWYER MH, WEBB DE, BALOW JE, STRAUS SE: Acyclovir-induced renal failure. Clinical course and histology. Am J Med 84:1067, 1988
23. BEAN B, AEPPLI D: Adverse effects of high-dose intravenous Acyclovir in ambulatory patients with acute herpes zoster. J Infect Dis 151:362-365, 1984
24. BRIGDEN D, ROSLING AE, WOODS NC: Renal function after Acyclovir intravenous injection. Am J Med 73(1A):182-185, 1982
25. LIETMAN PS: Acyclovir clinical pharmacology. Am J Med 73(1A):193-196, 1982
26. SANTOS MFF, SANTOS OFP, BOIM MA, et al: Nephrotoxicity of acyclovir and ganciclovir in rats: Evaluation of glomerular hemodynamics. J Am Soc Nephrol 8:361-367, 1997
27. REEVES WB, WINTERS CJ, ZIMMIAK L, et al: Medullary thick limbs: Renal concentrating segments. Kidney Int 50(Suppl 57):S154-S164, 1996
28. SANDS JM, KOKKO J: Current concepts of the countercurrent multiplication system. Kidney Int 50(Suppl 57):S93-S99, 1996
29. FERNÁNDEZ-LLAMA P. ANDREWS P, ECELBARGER CA, et al: Concentrating defects in experimental nephrotic syndrome: Altered expression of aquaporins and thick ascending limb Na+ transporters. Kidney Int 54:170-179, 1998
30. KNEPPER MA, KIM GH, FERNÁNDES-LLAMA P, ECELBARGER C: Regulation of thick ascending limb transport by vasopressin. J Am soc Nephrol 10:628-634, 1999
31. MASILAMANI S, KNEPPER MA, BURG MB: Urine concentration and dilution, in The Kidney, edited by Brenner BM. Philadelphia, PA, Saunders. 2000, pp 595-635
32. KIM GH, ECELBARGER CA, MITCHELL C, et al: Vasopressin increases Na-K-2Cl cotransporter expression in thick ascending limb of Henle's loop. Am J Physiol 276:F96-F103, 1999
33. VERKMAN AS: Lessons on renal physiology from transgenic mice lacking aquaporin water channels. J Am Soc Nephrol 10:1126-1135, 1999
34. MARTIN PY, SCHRIER RW: Role of aquaporin-2 water channels in urinary concentration and dilution defects. Kidney Int 53(Suppl 65):S57-S62, 1998
35. VERKMAN AS, MITRA AK: Structure and function of aquaporin water channels. Am J Physiol 278:F13-F28, 2000
36. NIELSEN S, KWON TH, CHRISTENSEN BM, et al: Physiology and pathophysiology of renal aquaporins. J Am Soc Nephrol 10:647-663, 1999
37. EARM JH, CHRISTENSEN BM, FROKIAER J, et al: Decreased aquaporin-2 expression and apical plasma membrane delivery in kidney collecting ducts of polyuric hypercalcemic rats. J Am Soc Nephrol 9:2181-2193, 1998
38. GALLA JH, BOOKER BB, KUKE RG: Role of the loop segment in the urinary concentrating defect of hypercalcemia. Kidney Int 29:977-982, 1986